Pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema.
Moshfeghi Andrew A, Scott Ingrid U, Flynn Harry W, Puliafito Carmen A
AI Summary
Intravitreal triamcinolone can cause temporary, non-infectious pseudohypopyon (0.8% of injections) shortly after injection. This benign finding usually resolves spontaneously, requiring observation unless inflammation progresses.
Abstract
Purpose
To report pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema.
Design
Retrospective, noncomparative, consecutive case series.
Methods
Records were reviewed of all patients who developed pseudohypopyon after intravitreal triamcinolone acetonide injection at Bascom Palmer Eye Institute between January 1, 2002 and February 1, 2004.
Results
A total of 828 intravitreal triamcinolone acetonide injections were administered to 686 patients during the study period. A pseudohypopyon (fine white crystalline opacities in the inferior anterior chamber angle) and suspended white crystalline opacities in the aqueous humor developed after 7 of the 828 injections (0.8%); all pseudohypopyons occurred within 3 days of injection and resolved completely within 2 weeks. None of the 686 patients developed clinically suspected infectious endophthalmitis.
Conclusions
A transient pseudohypopyon may occur in the early postinjection period after intravitreal triamcinolone acetonide injection. Unless progressive intraocular inflammation occurs, close observational management is indicated.
MeSH Terms
Shields Classification
Related Articles5
Management of uveitic and chorioretinal conditions in pregnancy.
ReviewTriamcinolone Acetonide Subconjunctival Injection as Stand-alone Inflammation Prophylaxis after Phacoemulsification Cataract Surgery.
Cohort StudySafety and effectiveness of intravitreal dexamethasone implant in patients with ocular toxocariasis.
Retrospective StudyINCIDENCE OF STEROID-RELATED OCULAR HYPERTENSION AND CATARACT FORMATION AFTER SUB-TENON TRIAMCINOLONE IN NONUVEITIC PEDIATRIC PATIENTS.
Case SeriesCataract Surgery in Patients With Uveitis Treated With Systemic Therapy in the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study: Risk Factors and Outcomes.
Cohort StudyIs this article assigned to the wrong chapter(s)? Let us know.